Features of Treatment of Patients with Diabetes Mellitus Type 2 with Heart Failure (Literature Review)

Authors

  • V.I. Pankiv Ukrainian Scientific and Practical Centre for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Ministry of Healthcare of Ukraine, Kyiv http://orcid.org/0000-0002-9205-9530

DOI:

https://doi.org/10.22141/2224-0721.1.57.2014.76432

Abstract

Diabetes mellitus and heart failure are often comorbid conditions. The studies found that patients taking metformin as monotherapy (odds ratio 0.65 (0.48–0.87)) or in conjunction with other drugs (0.72 (0.59–0.90)), mortality rate is lower. Research results given in the survey confirm the efficacy of treatment for concomitant heart failure in patients with diabetes mellitus and show the benefits of using metformin to lower blood glucose levels in these patients.

Downloads

Download data is not yet available.

Author Biography

V.I. Pankiv, Ukrainian Scientific and Practical Centre for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Ministry of Healthcare of Ukraine, Kyiv

Department of Endocrine Disorders Prevention

Published

2022-02-21

How to Cite

Pankiv, V. (2022). Features of Treatment of Patients with Diabetes Mellitus Type 2 with Heart Failure (Literature Review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), (1.57), 97–100. https://doi.org/10.22141/2224-0721.1.57.2014.76432

Issue

Section

Literature Review

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>